Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Kubica

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Cardiology Journal|October 5, 2022
Opioids and oral P2Y12 receptor inhibitors: A drug-drug interactionJacek Kubica
Cardiology Journal|April 30, 2024
Should dual antiplatelet treatment be guided by lipoprotein(a) concentration?Jacek Kubica
Cardiology Journal|July 7, 2022
Does ticagrelor effectively inhibit platelets in patients undergoing mild therapeutic hypothermia or it does not?Jacek Kubica
Kardiologia Polska|June 13, 2009
[Drug-eluting stents - new standard of restenosis treatment]Marek Koziński, Jacek Kubica
Cardiology Journal|July 25, 2008
Thrombolysis in cardiac arrest: Initial enthusiasm temperedMarek Koziński, Jacek Kubica
Cardiology Journal|August 14, 2008
In search of understanding the endotheliumZofia Grabczewska, Jacek Kubica
Kardiologia Polska|July 25, 2012
[High platelet reactivity during reperfusion - a new risk factor of no reflow?]Marek Koziński, Jacek Kubica
Cardiology Journal|September 20, 2019
ISAR-REACT 5 - What have we learned?Jacek Kubica, Miłosz Jaguszewski
Kardiologia Polska|August 4, 2006
[Inflammatory response after coronary angioplasty - mechanisms and significance]Marek Koziński, Jacek Kubica
Cardiology Journal|July 25, 2008
No-reflow phenomenon: Achilles' heel of primary coronary angioplasty in acute myocardial infarctionJacek Kubica, Marek Koziński
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Cardiology Journal|October 5, 2022
Opioids and oral P2Y12 receptor inhibitors: A drug-drug interactionJacek Kubica
Cardiology Journal|April 30, 2024
Should dual antiplatelet treatment be guided by lipoprotein(a) concentration?Jacek Kubica
Cardiology Journal|July 7, 2022
Does ticagrelor effectively inhibit platelets in patients undergoing mild therapeutic hypothermia or it does not?Jacek Kubica
Kardiologia Polska|June 13, 2009
[Drug-eluting stents - new standard of restenosis treatment]Marek Koziński, Jacek Kubica
Cardiology Journal|July 25, 2008
Thrombolysis in cardiac arrest: Initial enthusiasm temperedMarek Koziński, Jacek Kubica
Cardiology Journal|August 14, 2008
In search of understanding the endotheliumZofia Grabczewska, Jacek Kubica
Kardiologia Polska|July 25, 2012
[High platelet reactivity during reperfusion - a new risk factor of no reflow?]Marek Koziński, Jacek Kubica
Cardiology Journal|September 20, 2019
ISAR-REACT 5 - What have we learned?Jacek Kubica, Miłosz Jaguszewski
Kardiologia Polska|August 4, 2006
[Inflammatory response after coronary angioplasty - mechanisms and significance]Marek Koziński, Jacek Kubica
Cardiology Journal|July 25, 2008
No-reflow phenomenon: Achilles' heel of primary coronary angioplasty in acute myocardial infarctionJacek Kubica, Marek Koziński
Pageof 31